# Brazilian Reality of Hepatocellular Carcinoma

> **NCT06230328** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 300 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatocellular Carcinoma by BCLC Stage
- Hepatocellular Carcinoma Stage I
- Hepatocellular Carcinoma Stage II
- Hepatocellular Carcinoma Stage III

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06230328
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-15
- **Primary completion:** 2024-11-14
- **Final completion:** 2024-11-14
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06230328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06230328, "Brazilian Reality of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06230328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*